World News

Puberty blockers trial paused after MHRA raises safety concerns

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

“Since potentially significant and, as yet, unquantified risk of long-term biological harms is present to participants and biological safety has not been definitively demonstrated in this proposed cohort, at the very least, there should be a graded/stepwise approach starting with those aged 14 as the lower limit of eligibility,” it reads.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button